A case of malignant insulinoma responsive to somatostatin analogs treatment

BACKGROUND: Insulinoma is a rare tumour representing 1–2% of all pancreatic neoplasms and it is malignant in only 10% of cases. Locoregional invasion or metastases define malignancy, whereas the dimension (> 2 cm), CK19 status, the tumor staging and grading (Ki67 > 2%), and the age of onset (&...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:BMC Endocr Disord
Hoofdauteurs: Caliri, Mariasmeralda, Verdiani, Valentina, Mannucci, Edoardo, Briganti, Vittorio, Landoni, Luca, Esposito, Alessandro, Burato, Giulia, Rotella, Carlo Maria, Mannelli, Massimo, Peri, Alessandro
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2018
Onderwerpen:
Case Report
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6307122/
https://ncbi.nlm.nih.gov/pubmed/30591061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-018-0325-4
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items